EXPE is in a sustained, powerful uptrend: the stock is up 35.30% over the past year versus 15.53% for the S&P 500, a relative strength advantage of 19.77 percentage points, and at $288.95 it sits at approximately 66% of its 52-week range of $185.34–$342.00. That positioning — well above the midpoint but roughly 15.5% below the high — is characteristic of a stock in a healthy uptrend that has digested a sharp run rather than one pinned at an overextended extreme. The 52-week range itself is unusually wide (about 84% from low to high), reflecting the violent sentiment swings of the past year, including a maximum drawdown of -37.44% at some point in the trailing period. The structural trend remains constructive as long as price holds above the rising 200-day area implied by the mid-$250s, where the stock consolidated in September.

Short-term momentum is positive but decelerating relative to the longer-term trend. The stock is up 0.69% over the past month and 7.51% over three months, both ahead of the S&P 500's 1.22% and 2.69% respectively, yet the 1-month relative strength of -0.53 shows EXPE has actually lagged the index slightly over the last 30 days after its explosive July–August rally from $259.94 on July 24 to a peak close of $339.13 on August 24 — a 30% move in a single month. The subsequent pullback to $259.04 on September 23 (-23.6% from the high) and the choppy recovery to $288.95 suggests a consolidation phase; the sharp 6.0% single-day jump on October 15 (from $274.69 to $291.87) on elevated volume of 2.27 million shares signals renewed institutional accumulation. Year-to-date performance of just 2.12% versus the S&P's 11.93% (relative strength -9.81 YTD) confirms that most of the 12-month gain was earned in the second half, and the stock is now working off an overbought condition from the summer spike.

Key technical levels are well defined: resistance sits at the $339–$342 zone (the August 24 close of $339.13 and the 52-week high of $342.00), while support rests at the September swing low of $259.04, with secondary support near the 52-week low of $185.34. A breakout above $342 would confirm the resumption of the primary uptrend and likely target new highs, whereas a breakdown below $259 would break the pattern of higher lows and put the $220–$230 May/June consolidation zone in play. With a beta of 1.362, EXPE is roughly 36% more volatile than the market, meaning position sizing should account for amplified drawdowns — the -37.44% max drawdown is a concrete reminder — and a short ratio of 3.28 days-to-cover indicates moderate but not extreme bearish positioning that could fuel squeezes on upside breaks.

Revenue is reaccelerating decisively: Q2 2026 revenue of $4.315 billion grew 13.97% year-over-year versus $3.786 billion in Q2 2025, a marked acceleration from the prior-year comparison, and the trailing four-quarter revenue base now supports consensus 2026 estimates of approximately $20.85 billion. The segment mix shows B2C at $2.677 billion, B2B at $1.493 billion, and Trivago at $145 million, with the B2B arm — selling white-label technology and inventory to partners like banks, airlines, and OTAs — now representing roughly 34% of segment revenue and acting as the key growth engine and diversifier against consumer demand shocks. Sequential progression from Q1 2026's $3.426 billion to Q2's $4.315 billion reflects normal travel seasonality, but the year-over-year acceleration (Q1 2026 revenue of $3.426 billion versus Q1 2025's $2.988 billion, +14.7%) confirms this is a genuine demand and share-gain story rather than a seasonal artifact, strengthening the investment case for multiple expansion.

Profitability has inflected sharply. Q2 2026 net income reached $878 million (20.3% net margin) versus $330 million (8.7% margin) a year earlier, with operating income of $1.031 billion and an operating margin of 23.9%, up from 14.0% in Q2 2025. Gross margin is exceptionally high and stable at 90.66% (versus 90.04% a year ago), consistent with the asset-light OTA model, while the company's 12.7% trailing operating margin and 8.78% net margin reflect the seasonal drag of Q1, when Expedia typically posts a small loss (Q1 2026 net loss of $6 million, dramatically improved from the -$200 million loss in Q1 2025). The margin trajectory is clearly upward — Q2 EBITDA of $1.547 billion (35.9% EBITDA margin) versus $704 million (18.6%) a year ago — driven by B2B mix, advertising revenue, and cost discipline, and the narrowing of the Q1 loss from -$200 million to -$6 million is a powerful signal of operating leverage.

Balance sheet and cash flow are strong but leverage-heavy. Trailing free cash flow is $5.044 billion, enormous relative to the $35.5 billion market cap (a ~14.2% FCF yield), and Q2 2026 operating cash flow of $1.478 billion comfortably funded $199 million of capex, $400 million of acquisitions, $986 million of debt repayment, and $270 million of buybacks. However, debt-to-equity stands at 5.19x (total debt to capitalization of 82.5%), and the current ratio of 0.73 reflects the OTA model's large deferred-booking liabilities rather than distress; cash on hand is a robust $9.084 billion. ROE of 100.8% is inflated by the thin equity base from years of buybacks, while ROA of 6.11% is the more meaningful profitability gauge; interest coverage of roughly 16.9x in Q2 provides ample cushion, and the company's ability to self-fund growth plus return capital (dividend yield 0.56%, payout ratio 15.5%) indicates low external-financing dependence despite the high headline leverage.